Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06095154

CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma

CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma: A Prospective, Multi-center, Randomized Controlled Phase III Clinical Study

Status
Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
474 (estimated)
Sponsor
Fujian Cancer Hospital · Other Government
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, phase III, prospective, multi-center trial in newly diagnosed nasopharyngeal carcinoma (NPC) patients without distant metastasis. The aim of this study is to evaluate the efficacy and safety of modified IMRT, of which CTV delineation was only based on geometric expansion from GTV.

Detailed description

All enrolled patients underwent intensity-modulated radiation therapy (IMRT). The IMRT technique was selected based on the equipment available at each treatment center and the patients' preferences, including IMRT, VMAT, or TOMOTHERAPY. According to our study design, all enrolled patients will be randomly assigned in a 1:1 ratio before radiation therapy. The target area definitions are based on the international ICRU reports No. 50 and No. 60. The specific target area definitions and prescribed doses for the two groups are as follows: 1. GTVp (70Gy/33Fx) Experimental Group: Gross tumor as seen on imaging and nasopharyngoscopy; Control Group: Gross tumor as seen on imaging and nasopharyngoscopy. 2. CTVp1 (60Gy/33Fx) Experimental Group: None; Control Group: GTVp + 5 mm + entire nasopharyngeal mucosa. 3. CTVp2 (54Gy/33Fx) Experimental Group: GTVp + 10 mm + entire nasopharyngeal mucosa; Control Group: GTVp + 10 mm + high-risk anatomical structures. 4. GTVn Experimental Group: Lymph nodes as seen on imaging; Control Group: Lymph nodes as seen on imaging. 5. CTVn Experimental Group: Defined according to CACA/CMDA guidelines; Control Group: Defined according to CACA/CMDA guidelines.

Conditions

Interventions

TypeNameDescription
RADIATIONCTV Delineation Based on Geometric Expansion From GTV in Nasopharyngeal CarcinomaCTVp2 is generated by expanding GTVp by 10 mm and including the nasopharyngeal mucosa.

Timeline

Start date
2025-01-01
Primary completion
2027-12-31
Completion
2030-12-31
First posted
2023-10-23
Last updated
2025-03-13

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06095154. Inclusion in this directory is not an endorsement.